Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Deuschle

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
NPJ Parkinson'S Disease|June 13, 2025
Elevated cerebrospinal fluid levels of SERPIN E1 in participants with lewy body diseasesMilan Zimmermann, Madeleine Fandrich, Meike Jakobi, et al.
Frontiers in Aging Neuroscience|March 21, 2018
Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's DiseaseDaniel Stoessel, Claudia Schulte, Marcia C Teixeira Dos Santos, et al.
NPJ Parkinson'S Disease|April 22, 2024
Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriersBenjamin Roeben, Inga Liepelt-Scarfone, Stefanie Lerche, et al.
Journal of Parkinson'S Disease|September 6, 2024
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's DiseaseMilan Zimmermann, Madeleine Fandrich, Meike Jakobi, et al.
Parkinsonism & Related Disorders|June 13, 2026
Impact of genetic variants in the longevity gene PPARGC1A and cerebrospinal fluid PPARγ levels on clinical trajectories in Parkinson's disease: Potential biomarkers for neurodegeneration and ageingMadeleine Fandrich, Claudia Schulte, Meike Jakobi, et al.
Plos One|March 4, 2016
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body DementiaWalter Maetzler, Willy Deleersnijder, Valérie Hanssens, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 24, 2020
CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive TrajectoriesStefanie Lerche, Isabel Wurster, Benjamin Röben, et al.
NPJ Parkinson'S Disease|March 11, 2023
Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PDStefanie Lerche, Milan Zimmermann, Benjamin Roeben, et al.
European Journal of Neurology|January 15, 2021
The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s diseaseMilan Zimmermann, Leonie Köhler, Marketa Kovarova, et al.
NPJ Parkinson'S Disease|December 1, 2025
Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson's diseaseKathrin Brockmann, Alice Ticca, Stefanie Lerche, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
NPJ Parkinson'S Disease|June 13, 2025
Elevated cerebrospinal fluid levels of SERPIN E1 in participants with lewy body diseasesMilan Zimmermann, Madeleine Fandrich, Meike Jakobi, et al.
Frontiers in Aging Neuroscience|March 21, 2018
Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's DiseaseDaniel Stoessel, Claudia Schulte, Marcia C Teixeira Dos Santos, et al.
NPJ Parkinson'S Disease|April 22, 2024
Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriersBenjamin Roeben, Inga Liepelt-Scarfone, Stefanie Lerche, et al.
Journal of Parkinson'S Disease|September 6, 2024
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's DiseaseMilan Zimmermann, Madeleine Fandrich, Meike Jakobi, et al.
Parkinsonism & Related Disorders|June 13, 2026
Impact of genetic variants in the longevity gene PPARGC1A and cerebrospinal fluid PPARγ levels on clinical trajectories in Parkinson's disease: Potential biomarkers for neurodegeneration and ageingMadeleine Fandrich, Claudia Schulte, Meike Jakobi, et al.
Plos One|March 4, 2016
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body DementiaWalter Maetzler, Willy Deleersnijder, Valérie Hanssens, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 24, 2020
CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive TrajectoriesStefanie Lerche, Isabel Wurster, Benjamin Röben, et al.
NPJ Parkinson'S Disease|March 11, 2023
Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PDStefanie Lerche, Milan Zimmermann, Benjamin Roeben, et al.
European Journal of Neurology|January 15, 2021
The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s diseaseMilan Zimmermann, Leonie Köhler, Marketa Kovarova, et al.
NPJ Parkinson'S Disease|December 1, 2025
Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson's diseaseKathrin Brockmann, Alice Ticca, Stefanie Lerche, et al.
Pageof 6